MarketPeel
Insider Trading Intelligence
JY

James F. Young

NVAX
DIRECTOR · NOVAVAX INC · CIK 0001219864
FILING MIX · LIFETIME49%/51%
BUYS
25
SELLS
26
TOTAL VALUE
$7.14M
COMPANIES
1
ACTIVE SINCE
Dec 2019
HOLDINGS NOW
51,760
AVG SELL PX
$84.78
TRADE KIND
SHOWING 51 / 51
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
15 backtested trades · 8 horizons · 2 pending
Forward-return performance of every backtestable P/S trade by James F. Young, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d15+66.67%-5.23%+0.16%-5.39%-9.52%
14d15+73.33%-5.04%+0.24%-5.29%-16.86%
30d15+53.33%+10.72%-0.47%+11.18%+4.85%
60d15+80.00%+16.05%+0.34%+15.71%-9.61%
90d15+86.67%+1.56%+0.18%+1.38%-14.18%
180d15+66.67%-2.29%+2.95%-5.25%-27.38%
1y15+86.67%-26.91%+10.74%-37.66%-64.61%
2y15(2 pending)+100.00%-73.16%+17.47%-90.63%-99.89%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
NVAX · 51,760 shares · as of Dec 31, 2024
019,71039,42059,13078,84020202021202220232024SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2019
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
FLOW · 25 buys / 26 sellsCOVERAGE · 21 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
NVAX
NOVAVAX INC
SALE
5,400$8.00$43.2K51,760Dec 31, 2024Jan 2, 2025View →
NVAX
NOVAVAX INC
SALE
4,600$8.48$39.0K57,160Dec 24, 2024Jan 2, 2025View →
NVAX
NOVAVAX INC
SALE
7,500$14.09$105.7K61,760Jun 21, 2024Jun 25, 2024View →
NVAX
NOVAVAX INC
SALE
6,393$13.62$87.1K70,367Jun 18, 2024Jun 21, 2024View →
NVAX
NOVAVAX INC
SALE
1,107$14.28$15.8K69,260Jun 18, 2024Jun 21, 2024View →
NVAX
NOVAVAX INC
PURCHASEGRANT
Stock grant
15,630$15.86$247.9K15,630Jun 12, 2024Jun 14, 2024View →
NVAX
NOVAVAX INC
PURCHASE
6,67076,760Jun 12, 2024Jun 14, 2024View →
NVAX
NOVAVAX INC
PURCHASEGRANT
Stock grant
10,42010,420Jun 12, 2024Jun 14, 2024View →
NVAX
NOVAVAX INC
SALE
6,6700Jun 12, 2024Jun 14, 2024View →
NVAX
NOVAVAX INC
PURCHASEGRANT
Stock grant
6,6706,670Jun 12, 2023Jun 13, 2023View →
NVAX
NOVAVAX INC
PURCHASEGRANT
Stock grant
7,7107,710Jun 12, 2023Jun 13, 2023View →
NVAX
NOVAVAX INC
SALE
4,6000Jun 10, 2023Jun 13, 2023View →
NVAX
NOVAVAX INC
PURCHASE
4,60068,590Jun 10, 2023Jun 13, 2023View →
NVAX
NOVAVAX INC
PURCHASE
1,40063,990Jun 17, 2022Jun 21, 2022View →
NVAX
NOVAVAX INC
SALE
1,4000Jun 17, 2022Jun 21, 2022View →
NVAX
NOVAVAX INC
PURCHASEGRANT
Stock grant
6,9006,900Jun 10, 2022Jun 14, 2022View →
NVAX
NOVAVAX INC
PURCHASEGRANT
Stock grant
4,6004,600Jun 10, 2022Jun 14, 2022View →
NVAX
NOVAVAX INC
SALE
300$75.10$22.5K62,590Mar 31, 2022Apr 4, 2022View →
NVAX
NOVAVAX INC
SALE
8,945$73.29$655.5K66,145Mar 31, 2022Apr 4, 2022View →
NVAX
NOVAVAX INC
SALE
3,255$74.25$241.7K62,890Mar 31, 2022Apr 4, 2022View →
NVAX
NOVAVAX INC
PURCHASE
3,750$25.60$96.0K78,840Dec 31, 2021Jan 4, 2022View →
NVAX
NOVAVAX INC
SALE
3,7500Dec 31, 2021Jan 4, 2022View →
NVAX
NOVAVAX INC
SALE
3,750$144.16$540.6K75,090Dec 31, 2021Jan 4, 2022View →
NVAX
NOVAVAX INC
PURCHASE
10,00075,090Jul 1, 2021Jul 6, 2021View →
NVAX
NOVAVAX INC
SALE
10,0000Jul 1, 2021Jul 6, 2021View →
NVAX
NOVAVAX INC
SALE
7,5900Jun 25, 2021Jun 29, 2021View →
NVAX
NOVAVAX INC
PURCHASE
7,59065,090Jun 25, 2021Jun 29, 2021View →
NVAX
NOVAVAX INC
PURCHASEGRANT
Stock grant
2,6002,600Jun 17, 2021Jun 22, 2021View →
NVAX
NOVAVAX INC
PURCHASEGRANT
Stock grant
1,4001,400Jun 17, 2021Jun 22, 2021View →
NVAX
NOVAVAX INC
SALE
37,5000Mar 25, 2021Mar 25, 2021View →
NVAX
NOVAVAX INC
SALE
10,0000Mar 25, 2021Mar 25, 2021View →
NVAX
NOVAVAX INC
PURCHASE
10,000$27.60$276.0K20,000Mar 25, 2021Mar 25, 2021View →
NVAX
NOVAVAX INC
PURCHASE
37,500$3.99$149.4K57,500Mar 25, 2021Mar 25, 2021View →
NVAX
NOVAVAX INC
PURCHASE
10,000$46.00$460.0K20,000Mar 23, 2021Mar 25, 2021View →
NVAX
NOVAVAX INC
SALE
2,446$229.41$561.1K10,000Mar 23, 2021Mar 25, 2021View →
NVAX
NOVAVAX INC
SALE
4,434$227.43$1.01M15,566Mar 23, 2021Mar 25, 2021View →
NVAX
NOVAVAX INC
SALE
3,120$228.42$712.7K12,446Mar 23, 2021Mar 25, 2021View →
NVAX
NOVAVAX INC
SALE
10,0000Mar 23, 2021Mar 25, 2021View →
NVAX
NOVAVAX INC
PURCHASE
10,00010,000Jan 1, 2021Jan 5, 2021View →
NVAX
NOVAVAX INC
SALE
10,00010,000Jan 1, 2021Jan 5, 2021View →
NVAX
NOVAVAX INC
SALE
1,0000Dec 31, 2020Jan 5, 2021View →
NVAX
NOVAVAX INC
SALE
9,000$112.98$1.02M2,000Dec 31, 2020Jan 5, 2021View →
NVAX
NOVAVAX INC
PURCHASE
1,000$50.00$50.0K1,000Dec 31, 2020Jan 5, 2021View →
NVAX
NOVAVAX INC
SALE
10,0000Dec 31, 2020Jan 5, 2021View →
NVAX
NOVAVAX INC
PURCHASE
10,000$51.40$514.0K11,000Dec 31, 2020Jan 5, 2021View →
NVAX
NOVAVAX INC
SALE
2,000$113.60$227.2K0Dec 31, 2020Jan 5, 2021View →
NVAX
NOVAVAX INC
PURCHASEGRANT
Stock grant
20,00020,000Dec 5, 2020Dec 8, 2020View →
NVAX
NOVAVAX INC
PURCHASEGRANT
Stock grant
15,18015,180Jun 25, 2020Jun 26, 2020View →
NVAX
NOVAVAX INC
PURCHASEGRANT
Stock grant
7,5907,590Jun 25, 2020Jun 26, 2020View →
NVAX
NOVAVAX INC
PURCHASE
1,500$48.83$73.2K1,500Jun 3, 2020Jun 5, 2020View →
NVAX
NOVAVAX INC
PURCHASEGRANT
Stock grant
37,50037,500Dec 12, 2019Mar 24, 2020View →
Other insiders · NVAX
Loading peer insiders…
About this filer
CIK 0001219864
ROLE
Director
PRIMARY
NVAX
COMPANIES
1
ACTIVE SINCE
Dec 2019
MARKETPEEL · /INSIDER/0001219864DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback